News

Health and fitness companies focus on improving and maintaining physical well-being through products and services including ...
Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...
Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...
Short interest in Hims & Hers Health Inc rose to a record high, even as shares surged following strong first-quarter results.
WeightWatchers filed for bankruptcy on Tuesday as Americans shunned its offerings in favor of Novo and Lilly drugs and copies ...
Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers ...
Former Meta and Time Warner exec Mark D'Arcy is joining Microsoft as a corporate vice president working on the tech ...
Today's Forbes Daily newsletter covers billionaire security squads, Bill Gates’ 99% pledge, new Hims & Hers billionaire, ...
Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.
Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.
As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding ...
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...